Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease

Bruce E. Sands*, William J. Sandborn, Douglas C. Wolf, Seymour Katz, Michael Safdi, David A. Schwartz, Stephen B. Hanauer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

GOALS: Two uncontrolled, multicenter feasibility studies evaluated safety and pilot efficacy of selective granulocyte and monocyte adsorption apheresis (GMA) with the Adacolumn Apheresis System for treatment of moderate-to-severe ulcerative colitis (UC) and Crohn disease (CD) patients refractory/intolerant to conventional pharmacologic therapy. BACKGROUND: Patients with UC and CD, characterized by elevations in peripheral blood granulocytes, monocytes/macrophages, and proinflammatory mediators, may benefit from reductions in activated granulocytes and monocytes by selective apheresis. METHODS: Patients underwent weekly Adacolumn sessions for 5 weeks. Pilot efficacy assessments used disease activity index (DAI) for UC (0-12) or CD activity index (CDAI; 0-600) for CD. RESULTS: Eleven of 15 UC patients completed all 5 treatments. Mean DAI scores fell from 8.4±1.3 (baseline) to 5.2±2.9 (week 7). Five patients had DAI reductions of ≥ 3 points at week 7. Fourteen of 15 CD patients completed all 5 treatments. Mean CDAI scores fell from 308.0±76.5 (baseline) to 200.6±117.4 (week 7). Nine CD patients responded (CDAI reductions ≥ 70 points) at week 7. Remission (CDAI score ≤150 at week 7) was observed in 6 patients. There were no device-related serious adverse effects. CONCLUSIONS: Treatment with Adacolumn may be feasible and effective in patients with moderate-to-severe refractory inflammatory bowel disease. Larger sham-controlled studies are ongoing.

Original languageEnglish (US)
Pages (from-to)482-489
Number of pages8
JournalJournal of Clinical Gastroenterology
Volume40
Issue number6
DOIs
StatePublished - Jul 1 2006

Keywords

  • Crohn disease
  • Granulocytes
  • Inflammatory bowel disease
  • Leukocytapheresis
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease'. Together they form a unique fingerprint.

Cite this